BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2462565)

  • 1. Chemotherapy in head and neck cancer with bleomycin, cisplatinum, and methotrexate.
    Deitmer T; Urbanitz D
    J Cancer Res Clin Oncol; 1988; 114(6):644-6. PubMed ID: 2462565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined with radiotherapy in advanced head and neck cancer.
    Kuten A; Zidan J; Cohen Y; Robinson E
    Cancer Treat Rep; 1983 Jun; 67(6):573-4. PubMed ID: 6190559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer.
    Zidan J; Kuten A; Cohen Y; Robinson E
    Cancer; 1987 Jan; 59(1):24-6. PubMed ID: 2431756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy with cisplatin, bleomycin and methotrexate in advanced head and neck cancer--lack of therapeutic gain.
    Villar A; Pera J; Arellano A; Galiana R; Villá S; Farrus B; Hernandez M
    Radiother Oncol; 1987 Nov; 10(3):175-81. PubMed ID: 2448846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J
    J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
    Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
    Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.
    Campbell JB; Dorman EB; McCormick M; Miles J; Morton RP; Rugman F; Stell PM; Stoney PJ; Vaughan ED; Wilson JA
    Acta Otolaryngol; 1987; 103(5-6):519-28. PubMed ID: 3303823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
    Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.
    Rozencweig M; Dodion P; Bruntsch U; Gallmeier W; Clavel M; Gignoux B; Cortes Funes H; Cavalli F; Kirkpatrick A; Dalesio O
    Cancer; 1984 Oct; 54(8):1499-503. PubMed ID: 6206936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin.
    Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ
    Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of combined therapeutic modalities in head, neck, and esophageal cancer.
    Desai PB; Vyas JJ; Sharma S; Advani SH; Gopal R; Saikia TK; Dinshaw KA; Pinto JM; Swaroop VS
    Semin Surg Oncol; 1985; 1(3):116-31. PubMed ID: 2414837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early recurrence following induction chemotherapy for stage IV head and neck cancers: rationale for additional therapy.
    O'Donnell MR; Mohr RM; Baxter DH
    J Surg Oncol; 1985 Mar; 28(3):207-8. PubMed ID: 2579294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in stage III and IV squamous cell carcinoma of the head and neck.
    Klima A; Klippstein T; Bergmann L; Szepesi S; Ilberg CV
    J Laryngol Otol; 1988 Apr; 102(4):337-40. PubMed ID: 2455011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.
    Ensley JF; Jacobs JR; Weaver A; Kinzie J; Crissman J; Kish JA; Cummings G; Al-Sarraf M
    Cancer; 1984 Sep; 54(5):811-4. PubMed ID: 6204738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.